[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-246936-105":53,"doc-detail-246936-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","developing-raci-models-for-cross-departmental-regulatory-project-planning","Developing RACI Models for Cross-Departmental Regulatory Project Planning","","Effective regulatory project planning in the pharmaceutical and medical device industries depends on clear role definitions, transparent communication pathways, and strong accountability structures. The RACI matrix (Responsible, Accountable, Consulted, Informed) provides a structured way to assign responsibilities, reduce overlaps, and support collaboration across regulatory affairs, quality assurance, clinical operations, and manufacturing. This manuscript proposes a tailored five-step framework, validated through interviews and document analyses across multinational firms, showing measurable reductions in cycle time and review iterations while improving on-time delivery and stakeholder engagement.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/developing-raci-models-for-cross-departmental-regulatory-project-planning/246936/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/developing-raci-models-for-cross-departmental-regulatory-project-planning/246936.png","ImageObject",442,249,{"name":88,"@type":89},"Alex Sinclair","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-09-20","2026-09-12",true,{"@type":98,"interactionType":99,"userInteractionCount":76},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the role of the RACI matrix in regulatory project planning?","Question",{"text":108,"@type":109},"The RACI matrix assigns each task to Responsible, Accountable, Consulted, and Informed roles, clarifying ownership and streamlining cross-stakeholder communication in regulatory work.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What five-step framework does the manuscript propose for developing RACI models?",{"text":113,"@type":109},"The framework covers Stakeholder Identification, Task Decomposition, Matrix Drafting, Validation Workshops, and Integration & Monitoring.",{"name":115,"@type":106,"acceptedAnswer":116},"What improvements are reported after implementing the tailored RACI approach?",{"text":117,"@type":109},"Quantitative results report about a 30% reduction in dossier cycle time, a 27% decrease in review iterations, and a 20-percentage-point increase in on-time deliverables.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},246936,1789239061,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":76,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":8,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":125,"read_time":79},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Dr Kamal Kumar Gola et al. / International Journal for Research in Management and Pharmacy  \nVol. 15, Issue 03, March: 2026  \n(IJRMP) ISSN (o): 2320-0901  \nDeveloping RACI Models for Cross-Departmental Regulatory  \nProject Planning  \nDr Kamal Kumar Gola  \nCOER University, Roorkee Uttarakhand, India  \n[kkgolaa1503@gmail.com](kkgolaa1503@gmail.com)  \nABSTRACT  \nEffective regulatory project planning in the  \npharmaceutical and medical device industries hinges on  \nunambiguous role definitions, transparent  \ncommunication pathways, and rigorous accountability  \nframeworks. The RACI (Responsible, Accountable,  \nConsulted, Informed) matrix offers a structured  \napproach to delineate responsibilities, minimize overlaps,  \nand foster collaboration among cross-functional teams  \nspanning regulatory affairs, quality assurance, clinical  \noperations, and manufacturing. While RACI’s merits are  \nwell documented in generic project management  \nliterature, its tailored application within regulatory  \ncontexts remains underexplored. This manuscript  \nadvances a comprehensive five-step framework for  \ndeveloping bespoke RACI models that align with  \nregulatory submission milestones, organizational  \nhierarchies, and compliance requirements. Grounded in a  \nmixed-methods study—comprising in-depth interviews  \nwith fifteen senior project stakeholders and document  \nanalyses of two major submissions across three  \nmultinational pharmaceutical firms—the framework  \nemphasizes stakeholder mapping, task decomposition,  \niterative validation, and digital integration. Quantitative  \nresults reveal a 30% reduction in dossier cycle time, a 27% decrease in review iterations, and a 20-percentagepoint increase in on-time deliverables postimplementation. Qualitative insights highlight enhanced stakeholder engagement, improved decision-making clarity, and accelerated matrix drafting via pre-populated templates.  \nFigure-1.Streamlining Regulatory Project Management  \nKEYWORDS  \nRACI matrix, regulatory project planning, crossfunctional collaboration, accountability, pharmaceutical compliance  \nINTRODUCTION  \nRegulatory project planning in highly regulated industries—particularly pharmaceuticals and medical devices—presents unique challenges driven by stringent compliance standards, evolving global regulations, and intricate stakeholder ecosystems. Across the regulatory lifecycle, functions such as regulatory affairs, quality assurance, clinical operations, manufacturing, and legal must synchronize activities ranging from dossier compilation and audit readiness to post-approval pharmacovigilance. Yet, conventional project governance models often fall short, leaving responsibilities ill-defined and communication pathways fragmented. Misalignments  \ncan cascade into redundant workstreams, extended review  \n 34 Online International, Peer-Reviewed, Refereed & Indexed Monthly Journal   \nDr Kamal Kumar Gola et al. / International Journal for Research in Management and Pharmacy  \nVol. 15, Issue 03, March: 2026  \n(IJRMP) ISSN (o): 2320-0901  \nloops, compliance risks, and, ultimately, delayed market entry—each carrying substantial financial and public health implications.  \nFigure-2.Implementing RACI for Regulatory Success  \nThe RACI matrix, which assigns every project task to roles classified as Responsible (those executing tasks), Accountable (those owning final decisions), Consulted (those providing expertise), and Informed (those requiring updates), has risen to prominence as a straightforward instrument for clarifying accountabilities and streamlining stakeholder interactions (Kerzner, 2017) . However, generic RACI templates rarely account for domain-specific intricacies such as regulatory submission checkpoints (e.g., pre-IND meetings, dossier submissions, labeling reviews) or the layered approval hierarchies intrinsic to global pharmaceutical enterprises. As a consequence, organizations risk under-utilizing the matrix’s potential, overlooking nuanced interdepend","cbCaijawWrbCDj46","https://ap.wps.com/l/cbCaijawWrbCDj46","pdf",671994,"English","# Abstract\n# Keywords\n# Introduction\n# Literature Review","[{\"question\":\"What is the role of the RACI matrix in regulatory project planning?\",\"answer\":\"The RACI matrix assigns each task to Responsible, Accountable, Consulted, and Informed roles, clarifying ownership and streamlining cross-stakeholder communication in regulatory work.\"},{\"question\":\"What five-step framework does the manuscript propose for developing RACI models?\",\"answer\":\"The framework covers Stakeholder Identification, Task Decomposition, Matrix Drafting, Validation Workshops, and Integration \\u0026 Monitoring.\"},{\"question\":\"What improvements are reported after implementing the tailored RACI approach?\",\"answer\":\"Quantitative results report about a 30% reduction in dossier cycle time, a 27% decrease in review iterations, and a 20-percentage-point increase in on-time deliverables.\"}]","Developing RACI Models for Cross-Departmental Regulatory Project Planning | PDF"]